Table of Contents (December 2002)

Table of Contents

External Link - article-40064.pdf

Articles in this issue

over 23 years ago

Article

The Pain Pipeline

over 23 years ago

Article

FDA in Motion

over 23 years ago

Article

Every Employee, Every Day

over 23 years ago

Article

The Geometry of Risk

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Table of Contents (December 2002)

Articles in this issue

Related Content

Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma

Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

The New Healthy Aging Imperative and What It Means for Pharma

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

Trending on PharmExec

Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It

Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma

The New Healthy Aging Imperative and What It Means for Pharma

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

Reading Between the Lines: Closing the T1D Misdiagnosis Gap